FDA Approved: NETSPOT — Supplemental Application (Advanced Accelerator Applications USA, Inc)

View source ↗

Summary

The FDA approved a supplemental application for NETSPOT (68GA-DOTATATE) submitted by Advanced Accelerator Applications USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Neoplasm
• Neuroendocrine Tumor

Drugs mentioned

• NETSPOT (gallium-68 DOTATATE)

Snippet

SUPPL AP for NETSPOT (68GA-DOTATATE)